Summary:
Steve Forbes called him "America's leading authority in Nanotechnology." Josh is the author of "The Nanotech Report" and the monthly "Forbes/Wolfe Nanotech Report." He also is a co-founder and managing partner of venture capital firm Lux Capital, an investor in life sciences. Russ visits with a man who has conducted and published cutting-edge immunopathology research, lectured at Harvard University and completed a $4 billion hotel merger. What does it mean to you? Everything. Lux Capital is financing and making a bet on the future. OUR future. It's a fascinating discussion that explains where we're headed and ties a bow around it. This man is a rock star - and a fabulous interview.
